Ethicon Announces FDA Approval For SURGICEL Powder Absorbable Hemostat
Go back to Ethicon Announces FDA Approval For SURGICEL Powder Absorbable Hemostat| Johnson & Johnson (NYSE: JNJ) | Delayed: 257.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $257.77 | 52 Week High | $126.07 | |||
| Open | $257.77 | 52 Week Low | $94.28 | |||
| Day High | $257.77 | P/E | 53.59 | |||
| Day Low | $257.77 | EPS | $4.81 | |||
| Volume | 9,483 | |||||

